Core Scientific (CORZ) Accounts Payables (2021 - 2026)

Core Scientific (CORZ) has 6 years of Accounts Payables data on file, last reported at $218.9 million in Q1 2026.

• For the quarter ending Q1 2026, Accounts Payables rose 3358.55% year-over-year to $218.9 million; the trailing twelve-month figure through Mar 2026 stood at $218.9 million (up 3358.55% YoY), and the FY2025 full-year result was $126.1 million, up 554.59% from the prior year.
• Accounts Payables rose to $218.9 million in Q1 2026, from $126.1 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $218.9 million in Q1 2026 to a low of $6.3 million in Q1 2025.
• A 5-year average of $75.2 million and a median of $45.5 million in 2023 frame the typical range for Accounts Payables.
• Across the five-year window, Accounts Payables surged 18028.55% in 2022 and tumbled 87.55% in 2024, its largest moves.
• Tracing CORZ's Accounts Payables over 5 years: stood at $53.6 million in 2022, then jumped by 188.49% to $154.8 million in 2023, then plunged by 87.55% to $19.3 million in 2024, then jumped by 554.59% to $126.1 million in 2025, then surged by 73.55% to $218.9 million in 2026.
• Business Quant data shows CORZ's Accounts Payables at $218.9 million in Q1 2026, $126.1 million in Q4 2025, and $212.2 million in Q3 2025.